Latest Headlines

Latest Headlines

Beyond miniaturization: What's next for leadless pacemakers? Closed-loop tech

The medical device industry has been working on miniaturizing pacemakers so they can be minimally invasively inserted and cause fewer difficulties for patients. Up next likely are closed-loop systems: pacemakers that record patient data, transmit that data externally and enable adjustment based on that data by physicians or even, eventually, on their own as guided by advanced algorithms.

UPDATED: FDA approves first leadless transcatheter pacemaker for Medtronic, St. Jude up next

Medtronic has won the first U.S. approval for a leadless pacemaker from the FDA. The inch-long device is the smallest available and is implanted directly into the heart's right ventricle chamber. Traditional pacemakers require wired leads to connect the device to the heart.

St. Jude Medical will test its leadless pacemaker in a massive EU postmarketing trial

St. Jude Medical is embarking on a massive postapproval study in Europe for its Nanostim leadless pacemaker, barely weeks after beginning U.S. trials for the same device.

The top 10 med tech M&A deals of 2013

Forget organic growth. In 2013, some of the biggest moves into new or expanded markets in the med tech world came through serious M&A activity. The top deals announced or closed in 2013 created...

St. Jude puts the Nanostim leadless pacemaker in its first U.S. patient

A leadless pacemaker, approved for use in Europe, has found its way into its first U.S. patient, St. Jude Medical announced Thursday. Dr. Vivek Reddy implanted the Nanostim leadless pacemaker at The Mount Sinai Hospital in New York, starting a pivotal trial for FDA approval.

St. Jude places its Nanostim leadless pacemaker in a U.K. patient

After buying Nanostim just a few months ago, St. Jude Medical has implanted the company's eponymous leadless pacemaker in a patient in the U.K., a global first for a wireless device of its kind postapproval.

Analysts have high hopes for St. Jude in 2014

After months of regulatory woes and sluggish sales, St. Jude Medical has spent the past year cutting costs, trimming payroll and digging deep for some high-profile M&A. Now, after stringing together a few positive quarters, the company has won over many analysts and investors, setting the table for a big 2014.

Nanostim reports early human success with leadless pacer

Nanostim says its tiny wireless cardiac pacemaker has shown some success in its first three human patients, early signs that the potentially disruptive technology has legs. And the company's advance, presented this week at the Heart Rhythm Society meeting in Denver, may give it the lead over larger medical device rivals trying to come up with something similar.

Nanostim's leadless cardiac pacemaker proceeds in safety study

Nanostim, a small California startup, says it has successfully implanted a leadless cardiac pacemaker into 11 patients at a hospital in the Czech republic.

Nanostim signs investment deal with St. Jude

Milpitas, CA-based Nanostim has reached an agreement with St. Jude Medical, which has committed to a staged financing of the pacemaker developer, subject to it achieving certain development and